A PEGylated fibrin-based wound dressing with antimicrobial and angiogenic activity

Acta Biomaterialia

Volumn 7, Issue 7, 2011, Pages 2787-2796

  Seetharaman, Shanmuganathan ^a,c   Natesan, Shanmugasundaram ^a,c   Stowers, Ryan S ^b   Mullens, Conor ^d   Baer, David G ^a   Suggs, Laura J ^b   Christy, Robert J ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Pittsburgh Tissue Engineering Initiative Inc   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Adipose derived stem cells; Angiogenesis; Chitosan; PEGylated fibrin gel; Silver sulfadiazine

Indexed keywords

BACTERIA; CONTROLLED DRUG DELIVERY; EMULSIFICATION; EMULSIONS; GELS; PARTICLE SIZE; SILVER; STEM CELLS; TARGETED DRUG DELIVERY;

ADIPOSE DERIVED STEM CELLS; ANGIOGENESIS; CHITOSAN MICROSPHERES; CONDITION; FIBRIN GELS; IN-VITRO; PEGYLATED; PEGYLATED FIBRIN GEL; SILVER SULFADIAZINES; WOUND DRESSINGS;

CHITOSAN;

ANTIINFECTIVE AGENT; CHITOSAN; FIBRIN GEL; MACROGOL; MICROSPHERE; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; WATER OIL CREAM; WOUND HEALING PROMOTING AGENT;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG RELEASE; DRUG SYNTHESIS; FLOW KINETICS; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVASCULARIZATION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; WOUND DRESSING; WOUND INFECTION; X RAY MICROANALYSIS;

PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 79957684832     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.04.003     Document Type: Article

References (42)

1. Church D, Elsayed S, Reid O, et al. Burn wound infections. Clin Microbiol Rev 2006;19:403-34.
2. Keen EF, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al. Incidence and bacteriology of burn infections at a military burn center. Burns 2010;36(4):461-8.
3. D'Avignon LC, Saffle JR, Chung KK, Cancio LC. Prevention and management of infections associated with burns in the combat casualty. J Trauma 2008;64(Suppl. 3):S277-86.
4. Kennedy P, Brammah S, Wills E. Biofilm and a new appraisal of burn wound sepsis. Burns 2010;36(1):49-56.
5. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010;89(3): 219-29.
6. Masterton RG. The new treatment paradigm and the role of carbapenems. Int J Antimicrob Agents 2009;33(2):105-10.
7. Modak SM, Fox CL. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973;22:2391-404.
8. Stanford W, Rappole BW, Fox Jr CL. Clinical experience with silver sulfadiazine, a new topical agent for control of Pseudomonas infections in burns. J Trauma 1969;9:377-88.
9. Muller MJ, Hollyoak MA, Moaveni Z, Brown TL, Herndon DN, Heggers JP. Retardation of wound healing by silver sulfadiazine is reversed by aloe vera and nystatin. Burns 2003;29(8):834-6. (Pubitemid 37433921)
10. Harrison HN. Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension. Arch Surg 1979;114:281-5.
11. Tsipouras N, Rix CJ, Brady PH. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream. Clin Chem 1995;41:87-91.
12. Tsipouras N, Rix CJ, Brady PH. Passage of silver ions through membrane-mimetic materials, and its relevance to treatment of burn wounds with silver sulfadiazine cream. Clin Chem 1997;43:290-301. (Pubitemid 27066496)
13. Sano S, Fujimori R, Takashima M, Itokawa Y. Absorption, excretion and tissue distribution of silver sulfadiazine. Burns 1982;8:278-85. (Pubitemid 12115229)
14. Gear AJ, Hellewell TB, Wright HR, Mazzarese PM, Arnold PB, Rodeheaver GT, et al. A new silver sulfadiazine water soluble gel. Burns 1997;23:387-91. (Pubitemid 27515223)
15. Kawai K, Suzuki S, Tabata Y, Taira T, Ikada Y, Nishimura Y. Development of an artificial dermis preparation capable of silver sulfadiazine release. J Biomed Mater Res 2001;57:346-56. (Pubitemid 32885266)
16. Maitre S, Jaber K, Perrot JL, Guy C, Cambazard F. Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine. Ann Dermatol Venereol 2002;129(2):217-9. (Pubitemid 34263086)
17. Remunan-Lopez C, Bodmeier R. Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films. J Control Release 1997;44:215-25. (Pubitemid 27039118)
18. Lakshmi TS, Shanmugasundaram N, Shanmuganathan S, Karthikeyan K, Meenakshi J, Babu M. Controlled release of 2,3 desulfated heparin exerts its anti-inflammatory activity by effectively inhibiting E-selectin. J Biomed Mater Res A 2010;95(1):118-28.
19. Shanmuganathan S, Shanmugasundaram N, Adhirajan N, Ramyaa Lakshmi TS, Babu M. Preparation and characterization of chitosan microspheres for doxycycline delivery. Carbohyd Polym 2008;73:201-11.
20. Lakshmi TS, Shanmugasundaram N, Shanmuganathan S, Babu M. Efficacy of desulfated heparin mitigating inflammation in rat burn wound model. Appl Biomater 2011;97(2):215-23.
21. Natesan S, Baer DG, Walters TJ, Babu M, Christy RJ. Adipose-derived stem cell delivery into collagen gels using chitosan microspheres. Tissue Eng Part A 2010;16(4):1369-84.
22. Guo X, Park H, Young S, Kretlow JD, Van den Beucken JJ, Baggett LS, et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater 2010;6(1):39-47.
23. Lim SM, Oh SH, Lee HH, Yuk SH, Im GI, Lee JH. Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering. J Mater Sci Mater Med 2010;21(9):2593-600.
24. Zhang G, Wang X, Wang Z, Zhang J, Suggs L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng 2006;12(1):9-19.
25. Barthel LK, Raymond PA. Improved method for obtaining 3-microns cryosections for immunocytochemistry. J Histochem Cytochem 1990;38(9): 1383-8.
26. Franz TJ. The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Curr Probl Dermatol 1978;7:58-68.
27. Shanmugasundaram N, Ravikumar T, Babu M. Comparative physico-chemical and in vitro properties of fibrillated collagen scaffolds from different sources. J Biomater Appl 2004;18:247-64.
28. Bowler P. The anaerobic and aerobic microbiology of wounds: a review. Wounds 1998;10:170-8. (Pubitemid 128579732)
29. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard. eight ed. CLSI, Wayne, Pennsylvania:2009.M07-A8.ISBN: 1-56238-689-1.
30. Szycher M, Lee SJ. Modern wound dressings: a systematic approach to wound healing. J Biomater Appl 1992;7(2):142-213. (Pubitemid 23575944)
31. Arya N, Chakraborty S, Dube N, Katti DS. Electrospraying: a facile technique for synthesis of chitosan-based micro/nanospheres for drug delivery applications. J Biomed Mater Res B Appl Biomater 2009;88(1):17-31.
32. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J Control Release 2006;114(1):1-14. (Pubitemid 44131680)
33. Giovagnoli S, Blasi P, Ricci M, Schoubben A, Perioli L, Rossi C. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation. J Pharm Sci 2008;97(1):303-17.
34. Shanmugasundaram N, Sundaraseelan J, Uma S, Selvaraj D, Mary B. Design and delivery of silver sulfadiazine from alginate microspheresimpregnated collagen scaffold. J Biomed Mater Res B Appl Biomater 2006;77(2):378-88. (Pubitemid 43667461)
35. Burd A. Evaluating the use of hydrogel sheet dressings in comprehensive burn wound care. Ostomy Wound Manage 2007;53(3):52-62.
36. Liu H, Collins SF, Suggs LJ. Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials 2006;27(36): 6004-14. (Pubitemid 44414972)
37. US Pharmacopeia. Official Monographs: Silver Sulfadiazine Cream, USP 24- NF19. Rockville, MD, US, 1999. p. 1567.
38. Baghel PS, Shukla S, Mathur RK, Randa R. A comparative study to evaluate the effect of honey dressing and silver sulfadiazene dressing on wound healing in burn patients. Indian J Plast Surg 2009;42(2):176-81.
39. Caviggioli F, Vinci V, Salval A, Klinger M. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 2009;79(11):856.
40. Jackson WM, Nesti LJ, Tuan RS. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther 2010;10(4):505-17.
41. Zhang G, Drinnan CT, Geuss LR, Suggs LJ. Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. Acta Biomater 2010;6(9):3395-403.
42. Ozerdem U, Stallcup WB. Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 2003;6(3):241-9. (Pubitemid 38506669)